Back to mobile site

Wedbush Assumes Ascendis Pharma (ASND) at Outperform

November 4, 2024 4:39 PM EST Send to a Friend
Wedbush analyst Yun Zhong assumes coverage on Ascendis Pharma (NASDAQ: ASND) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login